MACROGENICS, INC. Capital Expenditures Incurred but Not yet Paid
MACROGENICS, INC. (MGNX) reported Capital Expenditures Incurred but Not yet Paid of $72.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-14
- MACROGENICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$204.00K.
- MACROGENICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $276.00K, a 21.81% decline year-over-year.
- MACROGENICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $47.00K, a 53.00% decline year-over-year.
- MACROGENICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$26.00K.
- MACROGENICS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $54.00K, a 46.00% decline from fiscal 2024.
- MACROGENICS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $100.00K, a 80.20% decline from fiscal 2023.
- MACROGENICS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $505.00K, a 327.97% increase from fiscal 2022.
- MACROGENICS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $118.00K, a 76.77% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $72.00K 10-Q · filed 2026-08-14 | $119.00K derived: sum of 3 quarters · filed 2026-08-14 | $93.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $276.00K 10-Q · filed 2026-05-13 | $323.00K derived: sum of 2 quarters · filed 2026-05-13 | $297.00K derived: sum of 3 quarters · filed 2026-05-13 | -$23.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $21.00K derived: sum of 2 quarters · filed 2026-03-09 | -$299.00K derived: sum of 3 quarters · filed 2026-08-14 | $54.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | -$26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$346.00K derived: sum of 2 quarters · filed 2026-08-14 | $7.00K 10-Q · filed 2025-11-12 | $107.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$320.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $33.00K 10-Q · filed 2026-08-14 | $133.00K derived: sum of 3 quarters · filed 2026-08-14 | $97.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $353.00K 10-Q · filed 2026-05-13 | $453.00K derived: sum of 2 quarters · filed 2026-05-13 | $417.00K derived: sum of 3 quarters · filed 2026-05-13 | $211.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $64.00K derived: sum of 2 quarters · filed 2026-03-09 | -$142.00K derived: sum of 3 quarters · filed 2026-03-09 | $100.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$242.00K derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $339.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | -$206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $36.00K 10-Q · filed 2025-08-14 | $375.00K derived: sum of 3 quarters · filed 2026-03-09 | $364.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $242.00K 10-Q · filed 2025-05-13 | $581.00K derived: sum of 2 quarters · filed 2026-03-09 | $570.00K derived: sum of 3 quarters · filed 2026-03-09 | $570.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $339.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $328.00K derived: sum of 2 quarters · filed 2026-03-09 | $328.00K derived: sum of 3 quarters · filed 2026-03-09 | $505.00K 10-K · filed 2026-03-09 |
| 2023-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$11.00K derived: sum of 2 quarters · filed 2024-11-05 | $166.00K 10-Q · filed 2024-11-05 | -$11.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $177.00K 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-03-31 | $177.00K 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $144.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2022-12-31 | -$177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$177.00K derived: sum of 2 quarters · filed 2025-03-20 | -$33.00K derived: sum of 3 quarters · filed 2025-03-20 | $118.00K 10-K · filed 2025-03-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $144.00K derived: sum of 2 quarters · filed 2023-11-06 | $295.00K 10-Q · filed 2023-11-06 | $734.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $295.00K 10-Q · filed 2023-08-09 | $734.00K derived: sum of 3 quarters · filed 2024-03-07 | $685.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $151.00K 10-Q · filed 2023-05-09 | $590.00K derived: sum of 2 quarters · filed 2024-03-07 | $541.00K derived: sum of 3 quarters · filed 2024-03-07 | $173.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $390.00K derived: sum of 2 quarters · filed 2024-03-07 | $22.00K derived: sum of 3 quarters · filed 2024-03-07 | $508.00K 10-K · filed 2024-03-07 |
| 2021-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$417.00K derived: sum of 2 quarters · filed 2022-11-03 | $69.00K 10-Q · filed 2022-11-03 | $135.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | -$368.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $118.00K 10-Q · filed 2022-08-08 | $184.00K derived: sum of 3 quarters · filed 2023-03-15 | $184.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $486.00K 10-Q · filed 2022-05-03 | $552.00K derived: sum of 2 quarters · filed 2023-03-15 | $552.00K derived: sum of 3 quarters · filed 2023-03-15 | $552.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $66.00K derived: sum of 2 quarters · filed 2023-03-15 | $66.00K derived: sum of 3 quarters · filed 2023-03-15 | $66.00K 10-K · filed 2023-03-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $66.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |